Navigation Links
Bend Research Offers Broad Access to Drug-Delivery Solutions
Date:10/20/2008

BEND, Ore., Oct. 20 /PRNewswire/ -- Bend Research Inc. announced today that it will independently offer unique drug-delivery expertise and technologies to outside firms in the pharmaceutical and biotechnology industries.

Bend Research will continue its 23-year collaboration with Pfizer but will also be free to work with outside firms using proprietary technologies developed jointly by the two firms.

These technologies include the spray-dried dispersion (SDD) technology (which increases the oral bioavailability of low-solubility compounds), controlled-release, multiparticulate, and pulmonary delivery platforms.

Bend Research CEO Rod Ray commented: "Our work with Pfizer has helped us tremendously to grow and develop our capabilities over the past two decades. In return, we have helped Pfizer advance a significant number of their compounds. Today, we're pleased to have the opportunity to collaborate with additional clients to enable the delivery of new medicines."

Kelvin Cooper, Senior Vice President of Worldwide Pharmaceutical Sciences for Pfizer Global Research and Development, agreed: "Our collaboration with Bend Research has proved to be valuable and we look forward to continued work with Bend Research. Through this agreement, we hope the technologies we've developed together will help speed the introduction of new medicines to patients throughout the world."

Under terms of the agreement with Pfizer, Bend Research will have the ability to employ expertise and processes developed with Pfizer to benefit other drug developers. These include optimized drug discovery, dosage form development, engineering capabilities, and manufacture of supplies for clinical trials under Good Manufacturing Practice (GMP) conditions.

Bend Research will continue to work exclusively with Pfizer on certain specific technology platforms. This commitment reaffirms the strong relationship between the two companies while providing enabling technologies for improved world health

About Bend Research Inc.

Bend Research Inc. is an interdisciplinary technology-, science-, and engineering-driven company that discovers, advances, develops, and commercializes pharmaceutical and healthcare products through the application of technology platforms. This capability is driven by scientific and engineering excellence. The company has three facilities based in Bend, Oregon.


'/>"/>
SOURCE Bend Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
2. The Wellness Community Announces National Cancer Survivorship Research & Training Institute in Philadelphia
3. Research May Help Predict Preeclampsia
4. Georgetown University Med Center reproductive health researchers tackle public health concerns
5. Monash wins $32m for health and medical research
6. New research shows that the smell of smoke does not trigger relapse in quitters
7. Stem-cell sentry sounds the alarm to maintain balance between cancer and aging, U-M researchers find
8. American Cancer Society awards research grants to 116 investigators at 75 institutions nationwide
9. Steroids aid recovery from pneumonia, UT Southwestern researchers say
10. Carnegie Mellon International Autism Symposium to Feature Groundbreaking Research, Oct. 17-18
11. MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class ... support to bring their novel lifesaving device for the everyday use of parents ... sensors, specially designed to read a child’s vital signs, and detect unusual symptoms ...
(Date:4/24/2017)... Ill., and Waycross, Ga. (PRWEB) , ... April ... ... market leader and trusted advisor within the telehealth industry, announces the company’s VideoMedicine ... U.S. board-certified primary care providers. Available 24 hours a day, Quick Care provides ...
(Date:4/24/2017)... ... April 24, 2017 , ... According ... overdose deaths now claim the lives of 62 Americans each day.(1) Yet since ... drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... ... 2017 , ... Pitavastatin, a relatively new statin, has relevance ... to have significant interactions with antiretroviral therapy (ART). Among people living with ... inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation are beneficial ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: